CGTX Cognition Therapeutics, Inc.
$0.98▲ +0.32%
Healthcare
Other
After hours
$0.98▲ +0.00%
Sep 11, 7:30 PM ET
Volume 218.0K
Avg Volume (10D) 323.4K
Key Metrics & Fundamentals
Market Cap
$93.46M
P/E Ratio
–
Div Yield
–%
52W Range
0.55 - 2.26
% vs 50 MA
-2.38%
% vs 200 MA
-17.00%
RSI-14
44.6
MACD Histogram
+0.0000
Beta (1Y vs SPY)
2.76
Free Cash Flow
-$3.07M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$3.87M
COGS
–
Operating Exp
$4.22M
Operating Income
-$4.22M
EBIT
-$4.22M
Pretax Income
-$3.93M
Net Income
-$3.93M
EPS (Diluted)
-0.04
Price & Volume History
Loading chart…
Recent News
Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference
GlobeNewswire · Sep 8, 2026 11:30 AM
Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 6, 2026 11:10 PM
Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update
GlobeNewswire · Aug 6, 2026 8:15 PM
Dementia-related Psychosis Market Gearing Up for Outstanding Expansion at a CAGR of 26.2% During the Forecast Period (2026-2036) | DelveInsight
PR Newswire · Aug 3, 2026 2:31 PM
Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit
GlobeNewswire · Jul 13, 2026 11:30 AM
Cognition Therapeutics Gets Positive FDA Feedback Over Phase 3 Study Of DLB Psychosis – But CGTX Stock Just Crashed 33%
Stocktwits · Jun 24, 2026 3:47 PM
Cognition Therapeutics Advances After FDA Supports Key Elements of Pivotal Trial Plan (CGTX)
InvestorsHub · Jun 24, 2026 12:46 PM
Cognition Therapeutics Agrees With FDA on Phase 3 Trial Framework for Psychosis Treatment
MT Newswires · Jun 24, 2026 12:23 PM
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
GlobeNewswire · Jun 24, 2026 11:30 AM
Cognition Therapeutics Receives Patent Allowance for Polymorphic Crystalline Form of Zervimesine
MT Newswires · Jun 16, 2026 12:19 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See CGTX's money flow as a full page
Social Sentiment
Avg +0.70 · 11 posts
PriceTargetTradeDiscussionThings are in transition. Long term thoughts.
r/wallstreetbets · Sep 16, 2025
CGTX is considered a good long-term investment at a specific price and the insider buying is a positive signal.
positive
+0.70
NewsDiscussionEarningsCGTX Loss
r/wallstreetbets · Sep 15, 2025
The post discusses a loss experienced with CGTX, and acknowledges its removal from a popular forum.
negative
+0.30
DDPriceTarget7 Figure YOLO in $CGTX, could be a 50-100xer
r/wallstreetbets · Sep 12, 2025
Strong bullish sentiment regarding undervaluation and potential 10x growth. Active discussion around the company.
very_positive
+0.80
DDTradePriceTarget7 figure YOLO in $CGTX, could be a 50-100XER- Play
r/wallstreetbets · Sep 12, 2025
Strong bullish sentiment expressed regarding the company's undervaluation and potential for significant growth.
very_positive
+0.90
DDDiscussionA more detailed post about why $CGTX is the real deal for a 50xer
r/wallstreetbets · Sep 12, 2025
The author describes CGTX as a 'real deal' and a 'blockbuster drug', indicating strong optimism.
positive
+0.80
Page 1 of 3 (11 total)
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.